Danish ingredients company Chr. Hansen said it experienced "solid" first-quarter sales growth boosted by its cultures and enzymes division.
Sales in local currencies increased by 12% in the quarter to reach EUR128m (US$181m).
Better product mix and improved margins resulted in a 19% growth in EBITDA to EUR40m. EBIT jumped 30% to reach EUR28m, despite the impact of foreign exchange.
"We have had a strong first quarter and are well prepared to capture future growth not least due to our EUR55m investment in the world's largest culture plant and our continued R&D spending. It is satisfactory to see that despite adverse exchange rates and challenging market conditions, we experience both solid top- and bottom-line growth, and we look forward to yet another robust year," said CEO Lars Frederiksen.
Sales growth was "strong" in all three of the group's divisions, Hansen said.
The firm's largest business division, cultures and enzymes, showed growth in local currencies of 10%.
Sales in the firm's health and nutrition division increased 25% in local currencies, while sales from the colour division grew 12%, also in local currencies.
For the full fiscal year 2009/10, Hansen said sales growth is expected to continue "in line with previous years". Profitability is expected to "grow faster than sales".
Sectors: Commodities & ingredients
View next/previous articles
20 Jan 2010 -
20 Jan 2010 -
Currently reading -
DENMARK: Chr. Hansen has “solid” first quarter
20 Jan 2010 -
20 Jan 2010 -
There is currently 1 comment on this article
Please note that Chr. Hansen is a DANISH company with presensence in more than 30 countries - including Germany. Helle Rexen, Chr. Hansen A/S
Helle Rexen said at 8:34 am, January 21, 2010
Reply to this comment